Array BioPharma

NASDAQ: ARRY
$16.21
-$0.03 (-0.2%)
Closing price June 18, 2021
Thursday's top analyst upgrades and downgrades included Array Technologies, Baker Hughes, Boeing, Cisco Systems, Coinbase, Deere, General Dynamics and Halliburton.
By late Wednesday morning, five brokerages had weighed in on Array Technologies, including Barclays and JPMorgan.
Wednesday's top analyst upgrades and downgrades included DraftKings, Dollar General, Hewlett Packard Enterprise, Novavax, Rackspace, Unity Software and Weyerhaeuser.
Thursday's top analyst upgrades and downgrades included AutoNation, Coinbase, Energy Transfer, First Solar, Ford, Okta, Pioneer Natural Resources and Planet Fitness.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Amazon, Bloom Energy, Chipotle and Disney.
Monday's top analyst upgrades and downgrades included Array Technologies, Baidu, Credit Suisse, Facebook, Franklin Resources, Twitter and ViacomCBS.
The focus on clean energy is set to remain at the forefront for a while. These four top Goldman Sachs solar stock picks are a way to play the potential, as they offer outstanding entry points for...
Analysts at Goldman Sachs have made some changes to price targets and ratings on 10 hot solar energy stocks.
Wednesday's top analyst calls included American Express, Apple, Baidu, CarMax, Chewy, Lululemon Athletica, Micron Technology, Moderna, Slack, Walt Disney and Zoom Video Communications.
Wall Street sees a Biden administration as a huge positive for clean energy. These five solar energy stocks are rated Buy at Goldman Sachs, and one is the newest member of the firm's Conviction List.
Monday's top analyst upgrades and downgrades included Albermarle, Biogen, Fisker, General Motors, Livent, Marriott International, Uber Technologies and Yelp.
Array Technologies, Inc. (NASDAQ: ARRY) has traded sharply higher on its debut in trading. The New Mexico-based maker of solar ground mounting systems and “trackers” priced its initial...
Stocks were indicated to open higher on Tuesday after a small gain in the Dow and S&P 500 on Monday. It may be the summer, but investors need to be considering how they want their portfolios and...
Array BioPharma shares shot up on Monday after the firm announced that it would be acquired by Pfizer in an all cash transaction. The boards of directors of both companies have approved the merger...
Top hedge funds now are bullish on these four red-hot price momentum stocks, according to a new Jefferies research report.